News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,705 Results
Type
Article (43652)
Company Profile (473)
Press Release (693568)
Multimedia
Podcasts (122)
Webinars (20)
Section
Business (209305)
Career Advice (2038)
Deals (36150)
Drug Delivery (119)
Drug Development (83957)
Employer Resources (174)
FDA (16683)
Job Trends (15185)
News (354121)
Policy (33274)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2655)
Accelerated approval (34)
Adcomms (28)
Allergies (141)
Alliances (51111)
ALS (176)
Alzheimer's disease (1718)
Antibody-drug conjugate (ADC) (325)
Approvals (16919)
Artificial intelligence (533)
Autoimmune disease (149)
Automation (37)
Bankruptcy (373)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (191)
Biotechnology (331)
Bladder cancer (162)
Brain cancer (59)
Breast cancer (646)
Cancer (4893)
Cardiovascular disease (414)
Career advice (1723)
Career pathing (37)
CAR-T (287)
CDC (46)
Celiac Disease (2)
Cell therapy (767)
Cervical cancer (36)
Clinical research (71380)
Collaboration (1768)
Company closure (4)
Compensation (1163)
Complete response letters (62)
COVID-19 (2769)
CRISPR (96)
C-suite (854)
Cystic fibrosis (152)
Data (6258)
Decentralized trials (2)
Denatured (39)
Depression (141)
Diabetes (500)
Diagnostics (6733)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (258)
Drug pricing (196)
Drug shortages (29)
Duchenne muscular dystrophy (240)
Earnings (91323)
Editorial (59)
Employer branding (21)
Employer resources (152)
Events (120928)
Executive appointments (993)
FDA (19803)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1514)
Gene editing (211)
Generative AI (44)
Gene therapy (636)
GLP-1 (1006)
Government (4752)
Grass and pollen (6)
Guidances (384)
Healthcare (19202)
HIV (57)
Huntington's disease (46)
IgA nephropathy (85)
Immunology and inflammation (270)
Immuno-oncology (58)
Indications (104)
Infectious disease (3033)
Inflammatory bowel disease (196)
Inflation Reduction Act (17)
Influenza (113)
Intellectual property (247)
Interviews (315)
IPO (16929)
IRA (52)
Job creations (3712)
Job search strategy (1439)
JPM (65)
Kidney cancer (15)
Labor market (83)
Layoffs (580)
Leadership (32)
Legal (8025)
Liver cancer (93)
Longevity (14)
Lung cancer (659)
Lymphoma (377)
Machine learning (43)
Management (59)
Manufacturing (797)
MASH (169)
Medical device (13908)
Medtech (13960)
Mergers & acquisitions (20288)
Metabolic disorders (1306)
Multiple sclerosis (161)
NASH (19)
Neurodegenerative disease (332)
Neuropsychiatric disorders (95)
Neuroscience (2992)
Neurotech (1)
NextGen: Class of 2026 (6770)
Non-profit (4580)
Now hiring (65)
Obesity (625)
Opinion (280)
Ovarian cancer (166)
Pain (203)
Pancreatic cancer (229)
Parkinson's disease (294)
Partnered (34)
Patents (491)
Patient recruitment (486)
Peanut (56)
People (60260)
Pharmaceutical (85)
Pharmacy benefit managers (30)
Phase 1 (22453)
Phase 2 (31472)
Phase 3 (23269)
Pipeline (5159)
Policy (294)
Postmarket research (2602)
Preclinical (9600)
Press Release (67)
Prostate cancer (243)
Psychedelics (55)
Radiopharmaceuticals (296)
Rare diseases (876)
Real estate (6063)
Recruiting (70)
Regulatory (24943)
Reports (51)
Research institute (2482)
Resumes & cover letters (353)
Rett syndrome (27)
RNA editing (21)
RSV (76)
Schizophrenia (154)
Series A (253)
Series B (196)
Service/supplier (11)
Sickle cell disease (103)
Special edition (26)
Spinal muscular atrophy (162)
Sponsored (42)
Startups (3803)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (85)
The Weekly (81)
Vaccines (1014)
Venture capital (93)
Weight loss (406)
Women's health (89)
Worklife (19)
Date
Today (22)
Last 7 days (619)
Last 30 days (2026)
Last 365 days (30630)
2026 (2929)
2025 (31063)
2024 (36297)
2023 (41014)
2022 (52277)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33023)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (754)
Alabama (89)
Alaska (7)
Arizona (314)
Arkansas (14)
Asia (40668)
Australia (6759)
California (11381)
Canada (3275)
China (1125)
Colorado (481)
Connecticut (489)
Delaware (335)
Europe (89129)
Florida (1672)
Georgia (357)
Hawaii (3)
Idaho (61)
Illinois (877)
India (63)
Indiana (519)
Iowa (24)
Japan (425)
Kansas (129)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1395)
Massachusetts (8279)
Michigan (322)
Minnesota (635)
Mississippi (5)
Missouri (127)
Montana (33)
Nebraska (28)
Nevada (121)
New Hampshire (83)
New Jersey (3031)
New Mexico (31)
New York (2982)
North Carolina (1520)
North Dakota (9)
Northern California (5522)
Ohio (334)
Oklahoma (21)
Oregon (45)
Pennsylvania (2281)
Puerto Rico (22)
Rhode Island (48)
South America (1121)
South Carolina (65)
South Dakota (1)
Southern California (4413)
Tennessee (173)
Texas (1752)
United States (40502)
Utah (339)
Vermont (1)
Virginia (264)
Washington D.C. (82)
Washington State (951)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
737,705 Results for "arcturus therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
·
1 min read
Press Releases
Arcturus Therapeutics to Attend Upcoming December 2025 Investor Conference
November 25, 2025
·
1 min read
Cystic fibrosis
Arcturus Plunges on ‘Mixed’ Cystic Fibrosis Data for Inhaled mRNA Drug
Despite showing no meaningful benefit on lung function, Arcturus’ mRNA therapy ARCT-032 reduced mucus volume in patients with cystic fibrosis—an outcome William Blair found “potentially promising.”
October 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Arcturus Therapeutics to Attend Upcoming November 2025 Investor Conferences
November 4, 2025
·
1 min read
Press Releases
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
November 10, 2025
·
14 min read
Press Releases
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program
October 23, 2025
·
8 min read
Press Releases
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
October 28, 2025
·
1 min read
Press Releases
Arcturus Therapeutics to Attend Upcoming September 2025 Investor Conferences
August 26, 2025
·
1 min read
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies
Arcturus is extending its cash runway into 2028 by discontinuing its early-stage vaccine candidates.
May 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Arcturus Therapeutics to Attend Upcoming Investor Conferences - July 23, 2025
July 24, 2025
·
1 min read
1 of 73,771
Next
